ARTV
Artiva Biotherapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Artiva Biotherapeutics (ARTV) Stock: Buy, Sell, or Hold?
$4.06
-0.16 (-3.79%)
▼
5d:
-3.33%
30d:
-40.03%
90d:
-64.79%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (77%)
Quality Score
53/100
Position
OVERSOLD
30-Day Fair Range
$4.41 – $6.76
Position: OVERSOLD
Forward P/E & Valuation
-2.1x
Next 12M consensus est.
Wall Street Target
$20.75
+411.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.04 / $4.39
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ARTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When ARTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARTV is currently trading at $4.06, which is considered oversold relative to its 30-day fair value range of $4.41 to $6.76.
Technical Outlook: Technically, ARTV is in a strong downtrend. The price is currently testing key support at $4.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.75 (+411.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARTV is in a strong downtrend. The price is currently testing key support at $4.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.75 (+411.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.41 -
$6.76
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$4.41 -
$6.76
Current vs Trading Range
OVERSOLD
Support Level
$4.04
Resistance Level
$4.39
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 411.1% below Wall St target ($20.75)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$20.75
(+411.1%)
Revenue Growth (YoY)
-100.0%
Share ARTV Analysis
Share this live ARTV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARTV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 1, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message suggests that Artiva Biotherapeutics ($ARTV) could partner with Chemomab to conduct the Phase 3 PSC trial for a specific drug, which Chemomab has been trying to do since 2024. No recent news articles were available.
Key Retail Themes:
potential partnership
Phase 3 PSC trial
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 40 SELL |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 49 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 37 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 72 BUY |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
16 analysts |
$51 | 62 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARTV Research Pages
